The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MSI exploration in patients with biliary tract cancer from the Spanish RETUD Registry.
 
Andrés J. Muñoz Martín
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Pfizer; Celgene; Daiichi Sankyo; Incyte; LEO Pharma; Lilly; MSD Oncology; Roche; Sanofi; SERVIER
Speakers' Bureau - Bayer; Menarini; Rovi; SERVIER; STADA
Research Funding - Celgene; LEO Pharma; Rovi; Sanofi
Patents, Royalties, Other Intellectual Property - Risk assessment model in venous thromboembolism in cancer patients
Travel, Accommodations, Expenses - Amgen; Celgene; Merck Serono; Pfizer; Roche; SERVIER
 
Teresa Macarulla
Consulting or Advisory Role - Ability Pharma; Advance Medical; Amgen; Aptitude Health; AstraZeneca; Basilea; Baxter; BioLineRX; Celgene; Eisai; Ellipses Pharma; Esteve; Incyte; Ipsen; Janssen; Lilly; Medscape; MFAR, Marketing Farmacéutico & Investigación Clínica; MSD; Novocure; Paraxel; Prime Oncology; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Zymeworks
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Agios (Inst); Amc Medical Research (Inst); Amgen (Inst); Armo Biosciences (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Basilea Pharmaceutical (Inst); Bayer (Inst); Beigene (Inst); BiolineRx (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (BMS) (Inst); Cantargia AB (Inst); Celgene (Inst); Eisai (Inst); ERYTECH Pharma (Inst); Fibrogen (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Incyte (Inst); Ipsen (Inst); Keralty Group (Inst); Lilly (Inst); Loxo (Inst); Medimmune (Inst); Merck Sharp & Dohme (Inst); Merrimack (Inst); Millennium (Inst); Nelum Corp. (Inst); Novartis (Inst); Novocure (Inst); OncoMed (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst); Roche (Inst); VCN Biosciences (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Incyte; Merck; Prime Oncology; Sanofi; SERVIER
 
Adelaida La Casta
No Relationships to Disclose
 
Jorge Adeva
No Relationships to Disclose
 
Oscar Alfredo Castillo Trujillo
No Relationships to Disclose
 
Paloma Peinado
No Relationships to Disclose
 
Helena Verdaguer
No Relationships to Disclose
 
Eva Martinez de Castro
No Relationships to Disclose
 
Miriam Lobo De Mena
Honoraria - LEO Pharma; Pfizer; SERVIER; Vifor Pharma
Consulting or Advisory Role - Fresenius Kabi
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Novartis; SERVIER
 
Monica Granja Ortega
No Relationships to Disclose
 
Rosa Maria Rodriguez-Alonso
No Relationships to Disclose
 
Ana Fernandez Montes
Consulting or Advisory Role - Amgen; Sanofi
Speakers' Bureau - Amgen; AstraZeneca; Celgene; Lilly; Lilly; Roche; Sanofi; Seagen; SERVIER
 
Ruth Vera
No Relationships to Disclose
 
Javier Gallego
Consulting or Advisory Role - AAA HealthCare; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Eisai Europe; Lilly; Merck Serono; Roche
Speakers' Bureau - Amgen; Ipsen; Lilly; Novartis
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst)
Expert Testimony - Bayer; Lilly
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
Other Relationship - Amgen; Amgen; Bristol-Myers Squibb; Merck
 
Begoña Graña
Research Funding - BMS GmbH & Co. KG; Merck; Roche
Travel, Accommodations, Expenses - Amgen; Merck; SERVIER
 
Ismael Ghanem
No Relationships to Disclose
 
Inmaculada Alés
Consulting or Advisory Role - BMS GmbH & Co. KG; Lilly
 
Raquel Molina
No Relationships to Disclose
 
Berta Laquente
No Relationships to Disclose
 
Enrique Aranda
No Relationships to Disclose